Calreticulin, a calcium-binding protein of the endoplasmic reticulum, has been found to function as a nuclear export factor for a large family of nuclear receptors. Atypical nuclear export pathways may thus exist that regulate the compartmentalization and activity of a distinct set of transcription factors. The transport of proteins between the nuclear and cytoplasmic compartments is mediated by a number of related nuclear transport factors [1, 2] . While their cargo and biological functions may be unique, the transport factors that participate in nuclear import -the importins -or export -the exportins -have common structural features that direct their interactions with components of the nuclear pore complex and the small monomeric GTP-binding protein, Ran [3] . The predominant pathway for nuclear protein export appears to be driven by the export factor Crm1, which recognizes a leucine-rich nuclear export signal sequence (NES) [1, 2] .
the repertoire of nuclear transport factors to include calreticulin, a calcium-binding protein initially found to reside predominantly within the endoplasmic reticulum [5] . Calreticulin is unrelated in sequence to previously described nuclear import and export factors [4] . Pashcal and coworkers identified calreticulin in their search for novel nuclear export factors using an in vitro nuclear export assay [4] . Initially, calreticulin was found to be able to substitute for Crm1, the prototypic nuclear export factor, in the in vitro nuclear export of the protein kinase inhibitor peptide, PKI. A mechanism for calreticulin's effects on PKI nuclear export was provided by data showing a direct interaction in vitro between calreticulin, a functional NES and Ran-GTP [4] . Calreticulin thus acts as a bona fide nuclear export factor in forming a complex with Ran-GTP when bound to an NES-containing cargo.
While calreticulin can be used by exporting substrates that participate in the Crm1 pathway, it also appears to be the major export factor for nuclear hormone receptors. Interestingly, the initial discoveries linking calreticulin and nuclear hormone receptors did not implicate calreticulin in receptor export. In 1994, two groups [6, 7] simultaneously reported their surprising findings of an inhibitory effect of calreticulin on the transactivation of nuclear hormone receptors. In vitro DNA-binding assays indicated that recombinant calreticulin could inhibit DNA binding by the androgen receptor, suggesting that calreticulin's effects on nuclear hormone receptor transactivation might be direct. Consistent with this, the calreticulin-binding region of nuclear receptor molecules was localized within a highly conserved region of their DNA-binding domain. Importantly, the calreticulin-interaction domain was included with a segment of the nuclear receptor DNA-binding domain -the DNA-recognition helix -that is essential for high-affinity DNA binding. Binding of nuclear receptor molecules to DNA or calreticulin should thus be mutually exclusive events.
Before the findings of Paschal's group [4] , the mechanism of nuclear protein export of nuclear hormone receptors had not been established and was a source of controversy in the field [8] [9] [10] . The glucocorticoid receptor, for example, does not appear to contain a leucine-rich NES, and in one study its export was found to be insensitive to leptomycin B, a specific inhibitor of the Crm1-dependent nuclear export [10] . Using a combination of in vitro and in vivo nuclear export assays and analysis of glucocorticoid receptor export in calreticulin-deficient cells, Paschal's group [4] provided compelling evidence for calreticulin's role in glucocorticoid receptor nuclear export. Consistent with the previous results which localized the calreticulin recognition motif within the glucocorticoid receptor DNA-binding domain [6, 7] , the calreticulin-dependent nuclear export signal of nuclear receptors was indeed found to be contained within their DNA-binding domain [4] . Calreticulin thus plays a dual role in limiting glucocorticoid receptor function by inhibiting its DNA-binding and mediating its removal from the nuclear compartment. It is unclear whether calreticulin uses a distinct pathway for the nuclear export of glucocorticoid receptor molecules, on the one hand, and leucine-rich NES cargo on the other, as the involvement of Ran-GTP in calreticulin-dependent nuclear export of glucocorticoid receptor has not been assessed.
In a study published recently in Current Biology, Paschal and co-workers [11] have now established calreticulin as an export factor for multiple nuclear hormone receptors, including steroid hormone, non-steroid hormone and orphan receptors. Importantly, they have shown that a highly conserved pair of adjacent phenylalanine residues within the DNA-recognition helix of nuclear receptors is critical for calreticulin binding in vitro and nuclear export in vivo. The apparent relatedness of nuclear export mechanisms for diverse members of the nuclear receptor superfamily implies that a competition could exist between different nuclear receptors for limiting amounts of the export factor calreticulin. As shown in carefully designed in vivo and in vitro co-expression studies [11] , competition for binding calreticulin between glucocorticoid receptor and vitamin D receptor molecules can limit nuclear export of the glucocorticoid receptor and influence the efficacy of glucocorticoid receptor transactivation. The extent to which competition for calreticulin contributes to cross-talk among the various nuclear receptors remains to be established in systems where biological relevance can be assessed.
Calreticulin is unique among nuclear export factors for its participation in so many diverse cellular functions. While calreticulin does not appear to be strictly confined to the endoplasmic reticulum, the extent of its nuclear localization remains controversial [4, 12, 13] . Furthermore, the mechanisms by which calreticulin molecules are imported into, and retained in, the nucleus are undefined. Deletion of the amino-terminal signal sequence of calreticulin appears to eliminate the protein's effects on glucocorticoid receptor transactivation in transiently transfected cells [13] , but does not influence its function as a nuclear export factor for the glucocorticoid receptor (B. Paschal, personal communication).
It is thus unclear whether nuclear localization of calreticulin is driven by its simple exclusion from the endoplasmic reticulum import machinery -via elimination of its amino-terminal signal sequence -or by its retrotranslocation from the endoplasmic reticulum to the cytoplasm. In recent years, our view of strict protein compartmentalization has been challenged as proteins that localize to focal adhesions [14] [15] [16] , endosomes [17] and plasma membrane [18] have been found to shuttle between the nuclear and cytoplasmic compartments. Calreticulin may have a similar capacity to localize to distinct subcellular compartments and act independently on compartment-specific targets. In fact, the limiting amounts of calreticulin within the nucleus may be biologically relevant, given the relatively inefficient nuclear export of nuclear hormone receptors [19] .
It is unclear why nuclear hormone receptors would have evolved such a distinct mechanism for nuclear export, given the diversity of related nuclear transport factors that accommodate a wide range of distinct cargoes. Perhaps the export of nuclear hormone receptors is linked to other processing steps that impact on subnuclear transport [10, 20] of the receptors or their productive interactions with the transcriptional machinery. The increased diversity in mechanisms of nuclear protein export highlighted by the studies of Paschal's group [4, 11] suggest that many more surprises await as more details of protein transport within the nucleus are uncovered.
